Get complete Patent Opposition Report for Laboratoire Franais Du Fractionnement Et Des Biotechnologies

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Laboratoire Franais Du Fractionnement Et Des Biotechnologies's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3481415Sep 6, 2023Stable Liquid Fibrinogen3
EP3806891Aug 2, 2023Combination Of Factor Vii And An Anti-Factor Ix/X Bispecific Antibody1
EP2651978Jan 12, 2022Use Of An Antibody Directed Against A Membrane Protein1
EP3390452May 26, 2021New Use Of An Anti-Cd303 Transmembrane Protein Antibody1
EP3277723Jun 17, 2020Cell Line Overexpressing Human Cd303 Antigen1
EP3116527Sep 4, 2019Method For Preparing Human Plasma Proteins2
EP2345425Jul 11, 2018Immunoglobulin G (Igg) Concentrate Depleted Of Anti-A And Anti-B Antibodies And Of Polyreactive Iggs2